(Q92267431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

review article

1 reference

title

Mechanisms of immunotherapy resistance: lessons from glioblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

1 reference

Christopher M Jackson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Michael Lim

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

author name string

John Choi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

publication date

29 July 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

page(s)

1100-1109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

Genetic alterations during colorectal-tumor development

28 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Socioeconomic Differences in the Epidemiologic Transition From Heart Disease to Cancer as the Leading Cause of Death in the United States, 2003 to 2015: An Observational Study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The concept of immune surveillance against tumors. The first theories

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Myeloid-derived suppressor cells coming of age.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Current state of immunotherapy for glioblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase 1 cohorts of CheckMate 143.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Epidemiology of gliomas

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

A restricted cell population propagates glioblastoma growth after chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Current State of Immunotherapy for Treatment of Glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immunotherapy for glioblastoma: playing chess, not checkers.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Nutrient transport systems in brain: 40 years of progress

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immunotherapy for brain cancer: recent progress and future promise

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Microglia emerge as central players in brain disease

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The myeloid cells of the central nervous system parenchyma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

A (delayed) history of the brain lymphatic system

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Drainage of cells and soluble antigen from the CNS to regional lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Structural and functional features of central nervous system lymphatic vessels

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The Meningeal Lymphatic System: A New Player in Neurophysiology

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

NKG2D-based CAR-T cells and radiotherapy exert synergistic efficacy in glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Brain Tumor Microenvironment and Host State: Implications for Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The somatic genomic landscape of glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Actively personalized vaccination trial for newly diagnosed glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immune checkpoint blockade: a common denominator approach to cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Immune Microenvironment in Glioblastoma Subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Tumour-associated macrophages as treatment targets in oncology.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Initiation of immune responses in brain is promoted by local dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Neoantigen-directed immune escape in lung cancer evolution

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

Neoantigen landscape dynamics during human melanoma-T cell interactions

1 reference

https://api.crossref.org/works/10.1038%2FS41590-019-0433-Y

7 January 2021

10.1038/S41590-019-0433-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31358997%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1 reference